Burn fat tastefully with fucoPROTEIN bars
WEST PALM BEACH, Fla. Garden of Life has introduced its fucoPROTEIN bar, a dietary supplement that contains fucoxanthin, a natural compound found in brown seaweed that burns fat and boosts metabolism. The bars are an extension of the company’s fucoTHIN supplement, currently the No. 1-selling supplement in the natural products industry, according to SPINSscan Natural, a market research firm.
“Many protein bars are glorified candy bars with little nutritional value,” said Garden of Life chief executive officer Jordan Rubin, author of the recently released book Perfect Weight America. “Not only are fucoPROTEIN bars a nutritious choice because they are made with organic ingredients instead of high fructose corn syrup, soy protein and artificial sweeteners, but they also can boost metabolism and assist with weight management.”
FucoPROTEIN bars are made with native whey protein, raw wildflower honey, acacia and chia seeds, which expand in the stomach and result in a feeling of satiety for hours. However, it’s the fat-burning properties of fucoxanthin that makes them unique in the market.
“FucoPROTEIN bars are an extension of our popular weight management category that includes fucoTHIN,” Rubin noted. Combined with a sensible diet and exercise program, clinical studies have shown that most people lose more weight using fucoTHIN than if they had chosen only to diet.”
For the 12-week period ended Dec. 1, 2007, fucoTHIN was the No. 1-selling product out of 225,000 products analyzed, according to SPINSscan. In clinical, double-blind human studies conducted on overweight women who followed an 1800-calorie meal plan, those taking fucoTHIN lost an average of 14.5 pounds while the placebo group lost an average of only three pounds.
Available in chocolate and peanut butter flavors, fucoPROTEIN bars retail for $2.99 while fucoTHIN has a suggested retail price of $49.99. Both products are available at health food stores nationwide.
Chattem issues recall of Icy Hot Heat Therapy products
CHATTANOOGA, Tenn. In what will quite possibly chill sales for the company, Chattem late Friday evening initiated a voluntary nationwide recall of its Icy Hot Heat Therapy products, including consumer “samples” that were included on a limited promotional basis in cartons of its 3 oz. Aspercreme product.
Chattem is recalling these products because it has received some consumer reports of first-, second- and third-degree burns as well as skin irritation resulting from consumer use, or possible misuse, of these products.
The number of adverse events reported to date represents less than one-tenth of one percent of the approximately 1.8 million units of product sold at retail, the company advised.
All lots and all sizes of the following Icy Hot Heat Therapy products are affected by this recall:
• Icy Hot Heat Therapy Air Activated Heat- Back
• Icy Hot Heat Therapy Air Activated Heat- Arm, Neck, and Leg
• Icy Hot Heat Therapy Air Activated Heat- Arm, Neck, and Leg single consumer use “samples” included on a limited promotional basis in cartons of 3 oz. Aspercreme Pain Relieving Creme.
The news comes only one week after Chattem chairman and chief executive officer Zan Guerry declared that Chattem “experienced the most successful year in its 128 year history” based on year-ending results for the period ending Nov. 30 reported Jan. 29.
Icy Hot is one of six brands that was expected to draw considerable advertising support in the coming year, Guerry had reported. The company’s total pain care products sales, which included Icy Hot, totaled $95.9 million for the fiscal year 2007, down 5 percent as compared to 2006. While sales behind the core Icy Hot brand had been strong, the company reported, sales of Icy Hot Pro-Therapy were disappointing. The recall impacts Chattem’s core icy Hot brand.
“If consumer sales are strong and growing, profits are going to follow,” Guerry told analysts last week. “Total Nielsen sales, excluding Pro-Therapy, were up 7.5 percent [for the month of December] and our big six brands [were] up double-digits as a group led by Gold Bond and Icy Hot, our two biggest brands, Gold Bond up 22 percent for December and Icy Hot up 30-percent-plus.”
Consequently, a drop in Icy Hot sales may negatively impact Chattem profits.
However, sales of Icy Hot Heat Therapy in fiscal 2007 represented only 2.3 percent of the company’s total revenues of $423 million and less than 1 percent of its total EBITDA, the company stated in a press release explaining the recall. For fiscal 2008, Icy Hot Heat Therapy was forecasted to represent less than 2 percent of total revenues and less than 1 percent of EBITDA. In the first quarter of fiscal 2008, Chattem expects to record a charge for the Icy Hot Heat Therapy recall related costs and expenses of approximately $6 million to $9 million, or $0.20 to $0.30 per share. The charge encompasses the return of products from the company’s distributors, retail customers and end-user consumers, impairment of the affected in-house inventory and other recall-related costs.
Chattem reiterated its previously forecasted earnings per share for fiscal 2008 of $4 to $4.20 and trend toward the upper end of this range, excluding the impact of the Icy Hot Heat Therapy recall charge, stock option expense and any loss on debt extinguishment.
Consumers who have the Icy Hot Heat Therapy products under recall should immediately stop using the products, discard them and/or return them to Chattem, the company stated.
Registration available for new CRN Workshop
WASHINGTON On Thursday, May 8th, The Council for Responsible Nutrition will be conducting a one-day symposium entitled The Workshop: CRN’s Day of Science. The workshop will take place at the Ritz Carlton Pentagon City Hotel, just outside of Washington, D.C., and will be divided in three sessions, featuring Tieraona Low Dog, from the University of Arizona, who will be the keynote speaker.
The first session will feature speakers David Perlmutter, of the Perlmutter Health Center, Jim LaValle, from the LaValle Metabolic Institute and the University of Cincinnati’s College of Pharmacy, and Aviad Haramati, from Georgetown University’s School of Medicine. All will be focusing on specifics in their field, but the overall purpose of the session is to explore and discuss the relationship between dietary supplements and chronic disease management.
The second session will be a discussion on the value of other types of scientific research for dietary supplements, as opposed to the reductionist approach. This session will feature the following speakers: Jeffrey Blumberg, from Tufts University’s Friedman School of Nutrition Science and Policy; Cheryl Ritenbaugh, at the University of Arizona; and Jonathan Berman, with the National Center for Complementary and Alternative Medicine’s Office of Clinical and Regulatory Affairs.
The third and final session will be focused on the processes to use in order to evaluate the identity of raw materials and, according to published reports, the role of industry facilitating method validation. Featured speakers include, Joseph Betz, in the Office of Dietary Supplements’ Dietary Supplements Methods and Reference Materials Program; Edward Kennelly, at Lehman College, the City University of New York’s Department of Biological Sciences; Paula Brown, from the British Columbia Institute of Technology’s Natural Health Product Research Group; Mark Roman, at Tampa Bay Analytical Research; and John Cardellina II, from the ReevesGroup.
Registration for the workshop is on a first-come-first-served basis. The fees for registration are $495 for CRN members and $595 for non-CRN members, and there is a rate of $295 for academic and government representatives. To register online—and review the full list of details—visit www.crnusa.org/TheWorkshop.